Serology for Plasmodium vivax malaria

This presentation will introduce P. vivax serological testing and treatment (PvSeroTAT), an emerging approach that uses serological markers to identify people at increased risk of relapse and guide targeted radical cure. Drawing on recent evidence and implementation experiences across multiple settings, the presentation will explore how PvSeroTAT is being considered and tailored to different epidemiological and programmatic contexts.